Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

Contents
Chapter 1
1. General introduction
1.1. Neuropathic pain
1.1.1. Diagnosis of neuropathic pain
1.1.2. Treatment of neuropathic pain
1.2. Quantitative Sensory Testing (QST)
1.2.1. QST and homogenous groups of somatosensory abnormalities
Chapter 2
Bilateral sensory abnormalities in patients with unilateral neuropathic
pain; a Quantitative Sensory Testing (QST) study
Abstract
1. Introduction
2. Methods
2.1. Description of healthy controls
2.2. Description of the patient cohort
2.3. Quantitative sensory testing (QST)
2.4. Data analysis and statistics
2.4.1. Z-transformation of QST data
2.4.2 Proportion of patients with sensory abnormalities at the affected side
2.4.3. Proportion of patients with sensory abnormalities at the contralateral side
2.4.4. Proportion of patients with sensory abnormalities for the same
QST parameter at the affected and contralateral side
2.4.5. Correlation between background pain and sensory abnormalities
2.4.6. Correlation between numbers of sensory abnormalities at the affected
and contralateral side
3. Results
3.1. QST observations in healthy controls
3.1.1. Sensory function in healthy controls
3.2. Demographics of patients
3.3. QST observations in patients
3.3.1. Sensory function in patients
3.3.2. Sensory changes at patients affected side
3.3.3. Sensory changes at the patient’s contralateral side
3.3.3.1. Example of magnitude of somatosensory abnormalities
13
15
17
19
19
21
22
25
26
27
28
28
28
29
29
29
30
30
30
31
31
31
31
31
32
34
34
36
38
39